The effectiveness of ibrutinib flexible dosing regimens on TTNT in CLL/SLL
Duration: 2:24
Views: 41
Submitted: 2 months ago
Tags:
speaker: nilanjan ghosh
institution: levine cancer institute
event: eha 2024
format: interview
subject: chronic lymphocytic leukemia
subject: leukemia
subject: small lymphocytic lymphoma
subject: lymphoma
field: treatment
field: real-world data
medicines: btk inhibitors
medicines: ibrutinib
cll
efficacy
safety
dose adjustment
sll
ttnt
flexible dosing regimen
dosing schedule
